0

Journal Articles

in Lipids and Lipid Disorders
 41-60 of 807 Articles
JAMA Pediatrics | 
Article |  August 01, 2012
Role of Waist Measures in Characterizing the Lipid and Blood Pressure Assessment of Adolescents Classified by Body Mass Index
Michael Khoury, MD; Cedric Manlhiot, BSc; Stafford Dobbin, MB, FCFP; et al.
Arch Pediatr Adolesc Med. 2012;166(8):719-724. doi:10.1001/archpediatrics.2012.126.
JAMA Internal Medicine | 
Invited Commentary |  June 25, 2012
Statins Work Just as Well in Women as in Men:  Comment on “Statin Therapy in the Prevention of Recurrent Cardiovascular Events”
Fiona Taylor, PhD, HonMFPH; Shah Ebrahim, DM, FRCP
Arch Intern Med. 2012;172(12):919-920. doi:10.1001/archinternmed.2012.2434.
JAMA | 
Editorial |  June 20, 2012
Use of Emerging Lipoprotein Risk Factors in Assessment of Cardiovascular Risk
Scott M. Grundy, MD, PhD
JAMA. 2012;307(23):2540-2542. doi:10.1001/jama.2012.6896.
JAMA | 
Original Contribution |  June 20, 2012 FREE
Lipid-Related Markers and Cardiovascular Disease Prediction
The Emerging Risk Factors Collaboration*
JAMA. 2012;307(23):2499-2506. doi:10.1001/jama.2012.6571.
INCLUDES: , Supplemental Content
JAMA | 
Viewpoint |  June 13, 2012
The Cost of Drug Coupons
David Grande, MD, MPA
JAMA. 2012;307(22):2375-2376. doi:10.1001/jama.2012.5603.
JAMA Internal Medicine | 
Editor's Correspondence |  June 11, 2012
Statins and the Risk of Diabetes: The Debate
Niki Katsiki, MSc, PhD, MD, FRSPH; Maciej Banach, MD, PhD, FAHA, FESC, FASA, FRSPH
Arch Intern Med. 2012;172(11):895-896. doi:10.1001/archinternmed.2012.1240.
JAMA Internal Medicine | 
Editor's Correspondence |  June 11, 2012
Statin Use and Risk of Diabetes
Harold Zeliger, PhD
Arch Intern Med. 2012;172(11):896-897. doi:10.1001/archinternmed.2012.1243.
JAMA Internal Medicine | 
Editor's Correspondence |  June 11, 2012
Statin Use and Risk of Diabetes—Reply
Annie L. Culver, BPharm; Ira S. Ockene, MD; Yunsheng Ma, MD, PhD
Arch Intern Med. 2012;172(11):896-897. doi:10.1001/archinternmed.2012.1613.
JAMA Internal Medicine | 
Invited Commentary |  May 14, 2012
Omega-3 Fatty Acids and Secondary Prevention of Cardiovascular Disease—Is It Just a Fish Tale?:  Comment on “Efficacy of Omega-3 Fatty Acid Supplements (Eicosapentaenoic Acid and Docosahexaenoic Acid) in the Secondary Prevention of Cardiovascular Disease”
Frank B. Hu, MD, PhD; JoAnn E. Manson, MD, DrPH
Arch Intern Med. 2012;172(9):694-696. doi:10.1001/archinternmed.2012.463.
JAMA Internal Medicine | 
Review Article |  May 14, 2012 FREE
Efficacy of Omega-3 Fatty Acid Supplements (Eicosapentaenoic Acid and Docosahexaenoic Acid) in the Secondary Prevention of Cardiovascular Disease:  A Meta-analysis of Randomized, Double-blind, Placebo-Controlled Trials
Sang Mi Kwak, MD; Seung-Kwon Myung, MD; Young Jae Lee, MD, MS; et al.
Arch Intern Med. 2012;172(9):686-694. doi:10.1001/archinternmed.2012.262.
JAMA Internal Medicine | 
Special Article |  May 14, 2012
Avoidance of Generic Competition by Abbott Laboratories' Fenofibrate Franchise
Nicholas S. Downing, AB; Joseph S. Ross, MD, MHS; Cynthia A. Jackevicius, PharmD, MSc; et al.
Arch Intern Med. 2012;172(9):724-730. doi:10.1001/archinternmed.2012.187.
JAMA Psychiatry | 
Original Article |  May 01, 2012 FREE
Cost-effectiveness of a Multicondition Collaborative Care Intervention:  A Randomized Controlled Trial
Wayne Katon, MD; Joan Russo, PhD; Elizabeth H. B. Lin, MD, MPH; et al.
Arch Gen Psychiatry. 2012;69(5):506-514. doi:10.1001/archgenpsychiatry.2011.1548.
JAMA Pediatrics | 
Review Article |  May 01, 2012 FREE
Novel Lipid-Based Approaches to Pediatric Intestinal Failure–Associated Liver Disease
Ivan R. Diamond, MD, PhD; Paul B. Pencharz, MBChB, PhD; Brian M. Feldman, MD, MSc; et al.
Arch Pediatr Adolesc Med. 2012;166(5):473-478. doi:10.1001/archpediatrics.2011.1896.
JAMA Internal Medicine | 
Special Article |  April 23, 2012
Cardiovascular Primary Prevention:  How High Should We Set the Bar?
Vinay Prasad, MD; Andrae Vandross, MD
Arch Intern Med. 2012;172(8):656-659. doi:10.1001/archinternmed.2012.812.
JAMA | 
Research Letters |  April 18, 2012 FREE
Use of Administrative Data to Estimate the Incidence of Statin-Related Rhabdomyolysis
James S. Floyd, MD, MS; Susan R. Heckbert, MD, PhD; Noel S. Weiss, MD, DrPH; et al.
JAMA. 2012;307(15):1580-1582. doi:10.1001/jama.2012.489.
JAMA | 
Editorial |  April 11, 2012
The Debut of Dueling Viewpoints
Howard Bauchner, MD; Phil B. Fontanarosa, MD, MBA
JAMA. 2012;307(14):1532. doi:10.1001/jama.2012.432.
JAMA | 
Viewpoint |  April 11, 2012
Statin Therapy for Healthy Men Identified as “Increased Risk”
Michael J. Blaha, MD, MPH; Khurram Nasir, MD, MPH; Roger S. Blumenthal, MD
JAMA. 2012;307(14):1489-1490. doi:10.1001/jama.2012.425.
JAMA | 
Viewpoint |  April 11, 2012
Healthy Men Should Not Take Statins
Rita F. Redberg, MD; Mitchell H. Katz, MD
JAMA. 2012;307(14):1491-1492. doi:10.1001/jama.2012.423.
JAMA Internal Medicine | 
Original Investigation |  April 09, 2012 FREE
B Vitamin and/or ω-3 Fatty Acid Supplementation and Cancer:  Ancillary Findings From the Supplementation With Folate, Vitamins B6 and B12, and/or Omega-3 Fatty Acids (SU.FOL.OM3) Randomized Trial
Valentina A. Andreeva, PhD; Mathilde Touvier, PhD; Emmanuelle Kesse-Guyot, PhD; et al.
Arch Intern Med. 2012;172(7):540-547. doi:10.1001/archinternmed.2011.1450.
JAMA | 
Review |  March 28, 2012 FREE
Association of LDL Cholesterol, Non–HDL Cholesterol, and Apolipoprotein B Levels With Risk of Cardiovascular Events Among Patients Treated With Statins:  A Meta-analysis
S. Matthijs Boekholdt, MD, PhD; Benoit J. Arsenault, PhD; Samia Mora, MD, MHS; et al.
JAMA. 2012;307(12):1302-1309. doi:10.1001/jama.2012.366.
INCLUDES: CME , Supplemental Content

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Internal Medicine
Viewpoint  |  May 6, 2013
Two New Drugs for Homozygous Familial Hypercholesterolemia:  Managing Benefits and Risks in a Rare Disorder
Robert J. Smith, MD; William R. Hiatt, MD
JAMA Internal Medicine
Research Letters  |  April 29, 2013
Limit to Benefits of Large Reductions in Low-Density Lipoprotein Cholesterol Levels: Use of Fractional Polynomials to Assess the Effect of Low-Density Lipoprotein Cholesterol Level Reduction in Metaregression of Large Statin Randomized Trials
Hisato Takagi, MD, PhD; Takuya Umemoto, MD, PhD; for the ALICE (All-Literature Investigation of Cardiovascular Evidence) Group
JAMA Internal Medicine
Invited Commentary  |  March 4, 2013
Getting to the Heart of HIV and Myocardial Infarction:  Comment on “HIV Infection and the Risk of Acute Myocardial Infarction”
Patrick W. G. Mallon, MB, BCh, PhD, FRACP, FRCPI
JAMA Internal Medicine
Research Letters  |  April 08, 2013
A National Survey of the Treatment of Hyperlipidemia in Primary Prevention
Michael E. Johansen, MD; Katherine J. Gold, MD, MSW, MS; Ananda Sen, PhD; et al.
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems